These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24319290)

  • 21. Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study.
    Lindblad C; Nelson DW; Zeiler FA; Ercole A; Ghatan PH; von Horn H; Risling M; Svensson M; Agoston DV; Bellander BM; Thelin EP
    J Neurotrauma; 2020 Jun; 37(12):1381-1391. PubMed ID: 32013731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.
    Cha E; Lee KM; Park KD; Park KS; Lee KW; Kim SM; Lee J
    PLoS One; 2016; 11(12):e0167819. PubMed ID: 27942009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
    Novakova L; Axelsson M; Malmeström C; Zetterberg H; Björkhem I; Karrenbauer VD; Lycke J
    J Neurol Sci; 2015 Nov; 358(1-2):201-6. PubMed ID: 26342940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.
    Bowman GL; Kaye JA; Moore M; Waichunas D; Carlson NE; Quinn JF
    Neurology; 2007 May; 68(21):1809-14. PubMed ID: 17515542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.
    Björkhem I; Lövgren-Sandblom A; Leoni V; Meaney S; Brodin L; Salveson L; Winge K; Pålhagen S; Svenningsson P
    Neurosci Lett; 2013 Oct; 555():102-5. PubMed ID: 24035896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.
    Miners JS; Kehoe PG; Love S; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2019 Sep; 11(1):81. PubMed ID: 31521199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated cerebrospinal fluid protein in POLG-related epilepsy: Diagnostic and prognostic implications.
    Hikmat O; Naess K; Engvall M; Klingenberg C; Rasmussen M; Tallaksen CME; Brodtkorb E; Fiskerstrand T; Isohanni P; Uusimaa J; Darin N; Rahman S; Bindoff LA
    Epilepsia; 2018 Aug; 59(8):1595-1602. PubMed ID: 29920680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels.
    Li YJ; Wang ZH; Zhang B; Zhe X; Wang MJ; Shi ST; Bai J; Lin T; Guo CJ; Zhang SJ; Kong XL; Zuo X; Zhao H
    J Neuroinflammation; 2013 Jul; 10():80. PubMed ID: 23829879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias.
    Musaeus CS; Gleerup HS; Høgh P; Waldemar G; Hasselbalch SG; Simonsen AH
    J Alzheimers Dis; 2020; 75(2):429-436. PubMed ID: 32280104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease.
    Chalbot S; Zetterberg H; Blennow K; Fladby T; Andreasen N; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2011; 25(3):505-15. PubMed ID: 21471645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease.
    Ahlskog JE; Tyce GM; Kelly PJ; van Heerden JA; Stoddard SL; Carmichael SW
    Exp Neurol; 1989 Aug; 105(2):152-61. PubMed ID: 2753115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Circulating Tight Junction Proteins in Evaluating Blood Brain Barrier Disruption following Intracranial Hemorrhage.
    Jiao X; He P; Li Y; Fan Z; Si M; Xie Q; Chang X; Huang D
    Dis Markers; 2015; 2015():860120. PubMed ID: 26586924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of systemic inflammation on human brain barrier function.
    Elwood E; Lim Z; Naveed H; Galea I
    Brain Behav Immun; 2017 May; 62():35-40. PubMed ID: 27810376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of 3 beta-hydroxy-5-cholestenoic acid, 3 beta,7 alpha-dihydroxy-5-cholestenoic acid, and 7 alpha-hydroxy-3-oxo-4-cholestenoic acid as normal constituents in human blood.
    Axelson M; Mörk B; Sjövall J
    J Lipid Res; 1988 May; 29(5):629-41. PubMed ID: 3411238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport of side-chain oxidized oxysterols in the human circulation.
    Babiker A; Diczfalusy U
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):333-9. PubMed ID: 9630709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxysterols as biomarkers in neurodegenerative diseases.
    Leoni V; Caccia C
    Chem Phys Lipids; 2011 Sep; 164(6):515-24. PubMed ID: 21515244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.
    Skillbäck T; Delsing L; Synnergren J; Mattsson N; Janelidze S; Nägga K; Kilander L; Hicks R; Wimo A; Winblad B; Hansson O; Blennow K; Eriksdotter M; Zetterberg H
    Neurobiol Aging; 2017 Nov; 59():1-9. PubMed ID: 28779628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood.
    Niklasson F; Agren H
    Biol Psychiatry; 1984 Aug; 19(8):1183-206. PubMed ID: 6498242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood-brain barrier damage.
    Bavaro DF; Calamo A; Lepore L; Fabrizio C; Saracino A; Angarano G; Monno L
    Infection; 2019 Jun; 47(3):441-446. PubMed ID: 30649685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective cholesterol metabolism in amyotrophic lateral sclerosis.
    Abdel-Khalik J; Yutuc E; Crick PJ; Gustafsson JÅ; Warner M; Roman G; Talbot K; Gray E; Griffiths WJ; Turner MR; Wang Y
    J Lipid Res; 2017 Jan; 58(1):267-278. PubMed ID: 27811233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.